A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer

A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer

Background: Indocyanine green (ICG) is a promising tracer for sentinel lymph node biopsy in early breast cancer. This randomized study was conducted to evaluate sentinel lymph node biopsy with ICG compared with blue dye as a tracer in woman with early breast cancer without any sign of lymph node inv...

Full description

Bibliographic Details
Main Authors: Michel Coibion, Fabrice Olivier, Audrey Courtois, Nathalie Maes, Véronique Jossa, Guy Jerusalem
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
sentinel lymph node
breast cancer
indocyanine green
Online Access:https://www.mdpi.com/2072-6694/14/4/888

Internet

https://www.mdpi.com/2072-6694/14/4/888

Similar Items